| Filed On | Filing |
|---|---|
| 16 Nov 2026 | 8-K: Entry into a Material Definitive Agreement; Other Events |
| 16 Nov 2026 |
8-K: Results of Operations and Financial Condition
Lexington, MA, November 16, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient ... |
| 07 Aug 2026 |
8-K: Results of Operations and Financial Condition
Lexington, MA, August 7, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient man... |
| 28 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
The Company held its annual meeting of stockholders on May 21, 2026 (the “Annual Meeting”), at which a quorum was present. There were two items of business acted upon by the stockholders. There were 41,267,511 shares of the Company’s Cla... |
| 19 May 2026 |
8-K: Entry into a Material Definitive Agreement
1. Introductory. Rapid Micro Biosystems, Inc., a Delaware corporation (the “Company”), proposes to sell, pursuant to the terms of this Underwriting Agreement (this “Agreement”), to the several underwriters named in Schedule A hereto (the... |
| 13 May 2026 |
8-K: Results of Operations and Financial Condition
Lexington, MA, May 13, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manuf... |
| 27 Mar 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
This letter agreement follows our conversations regarding your employment with Rapid Micro Biosystems, Inc. (the “Company”). Reference is made your Employment Agreement, dated as of July 8, 2021, between you and the Company (the “Employm... |
| 12 Mar 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Lexington, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient ... |
| 13 Jan 2026 |
8-K: Results of Operations and Financial Condition
LEXINGTON, Mass., January 13, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficien... |
| 07 Nov 2025 |
8-K: Results of Operations and Financial Condition
Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance |
| 12 Aug 2025 |
8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +3 more
Lexington, MA, August 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient ma... |
| 17 Jun 2025 |
8-K: Other Events
I am writing on a personal note to let you know that I was recently diagnosed with a treatable form of Lymphoma. The good news is that I have an excellent care team and my doctors have given me a very good prognosis. |
| 23 May 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 09 May 2025 |
8-K: Results of Operations and Financial Condition
Lexington, MA, May 9, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufa... |
| 04 Mar 2025 |
8-K: Regulation FD Disclosure
Rapid Micro Biosystems TD Cowen 45th Annual Health Care Conference Robert Spignesi, President & CEO March 4, 2025 R A P I D M I C R O B I O S Y S T E M S N A S D A Q : R P I D © 2025, Rapid Micro Biosystems, Inc. | RAPID MICRO BIOSYSTEMS... |
| 28 Feb 2025 |
8-K: Results of Operations and Financial Condition
Lexington, Mass., February 28, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficie... |
| 27 Feb 2025 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany |
| 16 Jan 2025 |
8-K: Regulation FD Disclosure
Rapid Micro Biosystems 43rd Annual J.P. Morgan Healthcare Conference Rob Spignesi, President & CEO January 16, 2025 R A P I D M I C R O B I O S Y S T E M S N A S D A Q : R P I D © 2025, Rapid Micro Biosystems, Inc. | RAPID MICRO BIOSYSTE... |
| 14 Jan 2025 |
8-K: Results of Operations and Financial Condition
LEXINGTON, Mass., January 14, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficien... |
| 12 Nov 2024 |
8-K: Other Events
As previously reported, on February 2, 2024, Rapid Micro Biosystems, Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC notifying the Company that... |
Loading...